Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
285
-
Total 13F shares, excl. options
-
57.6M
-
Shares change
-
-397K
-
Total reported value, excl. options
-
$5.08B
-
Value change
-
-$46.9M
-
Put/Call ratio
-
0.72
-
Number of buys
-
144
-
Number of sells
-
-155
-
Price
-
$88.25
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q1 2021
364 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q1 2021.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 285 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.6M shares
of 67.6M outstanding shares and own 85.13% of the company stock.
Largest 10 shareholders include FMR LLC (6.12M shares), VANGUARD GROUP INC (5.46M shares), Jackson Square Partners, LLC (3.71M shares), BlackRock Inc. (3.49M shares), Capital World Investors (3.09M shares), CREDIT SUISSE AG/ (2.03M shares), Invesco Ltd. (1.77M shares), Champlain Investment Partners, LLC (1.34M shares), FEDERATED HERMES, INC. (1.27M shares), and BROWN CAPITAL MANAGEMENT LLC (1.23M shares).
This table shows the top 285 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.